Global 2019-nCoV Test Kit Market Research Report 2022

Laboratory testing for the respiratory coronavirus disease 2019 (COVID-19) and the associated SARS-CoV-2 virus includes methods that detect the presence of virus and those that detect antibodies produced in response to infection. Detection of antibodies (serology) can be used both for clinical purposes and population surveillance.Using real time reverse transcription polymerase chain reaction (rRT-PCR) the test can be done on respiratory samples obtained by various methods, including nasopharyngeal swab or sputum sample.Results are generally available within a few hours to 2 days.Molecular methods leverage polymerase chain reaction (PCR) along with nucleic acid tests, and other advanced analytical techniques, to detect the genetic material of the virus using real-time reverse transcription polymerase chain reaction for diagnostic purposes.

Due to the COVID-19 pandemic, the global 2019-nCoV Test Kit market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe 2019-nCoV Test Kit market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe 2019-nCoV Test Kit landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Nucleic Acid Test Kit accounting for % of the 2019-nCoV Test Kit global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of 2019-nCoV Test Kit include Thermo Fisher Scientific, LabCorp, Cepheid, Hologic, Danaher, Roche Diagnostics, BioMérieux, Integrated DNA Technologies and Abbott Laboratories, etc. In terms of revenue, the global 3 largest players have a % market share of 2019-nCoV Test Kit in 2021.

This report focuses on 2019-nCoV Test Kit volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall 2019-nCoV Test Kit market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global 2019-nCoV Test Kit Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.



Segment by Type


Nucleic Acid Test Kit

Antibody Test Kit



Segment by Application


Hospital

Scientific Research

Diagnostic Center


By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE



By Company


Thermo Fisher Scientific

LabCorp

Cepheid

Hologic

Danaher

Roche Diagnostics

BioMérieux

Integrated DNA Technologies

Abbott Laboratories

Beijing Genomics Institute

Shanghai Huirui Biotechnology

Geneodx

Shanghai BioGerm Medical Biotechnology

Da An Gene

Wondfo

INNOVITA

Kogenebiotech

Mylab Discovery

Altona Diagnostics

Seegene

SD Biosensor

Biomaxima

Quidel

Qiagen

GenMark Diagnostics